1. The Heterochromatin protein 1 is a regulator in RNA splicing precision deficient in ulcerative colitis.
- Author
-
Mata-Garrido, Jorge, Xiang, Yao, Chang-Marchand, Yunhua, Reisacher, Caroline, Ageron, Elisabeth, Guerrera, Ida Chiara, Casafont, Iñigo, Bruneau, Aurelia, Cherbuy, Claire, Treton, Xavier, Dumay, Anne, Ogier-Denis, Eric, Batsché, Eric, Costallat, Mickael, Revêchon, Gwladys, Eriksson, Maria, Muchardt, Christian, and Arbibe, Laurence
- Subjects
ULCERATIVE colitis ,INFLAMMATORY bowel diseases ,ALTERNATIVE RNA splicing ,RNA splicing ,GENE silencing ,HETEROCHROMATIN - Abstract
Defects in RNA splicing have been linked to human disorders, but remain poorly explored in inflammatory bowel disease (IBD). Here, we report that expression of the chromatin and alternative splicing regulator HP1γ is reduced in ulcerative colitis (UC). Accordingly, HP1γ gene inactivation in the mouse gut epithelium triggers IBD-like traits, including inflammation and dysbiosis. In parallel, we find that its loss of function broadly increases splicing noise, favoring the usage of cryptic splice sites at numerous genes with functions in gut biology. This results in the production of progerin, a toxic splice variant of prelamin A mRNA, responsible for the Hutchinson-Gilford Progeria Syndrome of premature aging. Splicing noise is also extensively detected in UC patients in association with inflammation, with progerin transcripts accumulating in the colon mucosa. We propose that monitoring HP1γ activity and RNA splicing precision can help in the management of IBD and, more generally, of accelerated aging. This study reports reduced expression of the chromatin and splicing regulator HP1γ in inflammatory bowel disease (IBD) and shows that HP1γ protects against pervasive RNA splicing leading to toxic mRNA products detected in IBD, like progerin. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF